Drugmakers Must Report Clinical Trial Results Once Kept SecretBy
NIH rule requires disclosure even if FDA didn’t approve drug
Researchers risk losing NIH funding if they don’t comply
Pharmaceutical companies will no longer be able to keep confidential their clinical trial results for experimental drugs that aren’t approved for patient use.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.